Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxxeus Dental is a specialized provider of dental allografts and regenerative biologics, operating as a division of Solvita (formerly Community Tissue Services). The company offers a comprehensive portfolio of bone and soft tissue products, including particulate grafts, collagen membranes, and specialty allografts designed for oral and maxillofacial surgery. Their products are processed in state-of-the-art facilities to support clinical applications such as socket preservation, ridge augmentation, and periodontal defect repair. Maxxeus Dental is committed to advancing dental surgery through high-quality, sterile-processed human tissue that meets rigorous safety standards. The brand serves a global network of dental professionals and distributors from its headquarters in Ohio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxxeus Dental.